XPO1 and breast cancer: In a study of breast cancer, Western-blot data with IHC showed increased expression of CRM1 in breast cancer tissues compared to normal tissues, and this increase was associated with tumor size, advanced tumor stage, tumor invasion, extensive lymph node involvement, distant metastasis, and poor survival [44].